Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

bohemianclubman 54 posts  |  Last Activity: Feb 8, 2016 10:43 AM Member since: May 19, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • bohemianclubman bohemianclubman Dec 23, 2015 11:11 AM Flag

    Merry Christmas to you and your family H. I believe my bohemianclub ID was started in 2000 and in my many years of checking out various message boards your integrity and demeanor rise to the top. So much so that I will take your advice and even wish Terry a Merry Christmas. Merry Christmas Terry. BTW, can you believe that this year in Washington they are calling that sprawling spruce a Holiday tree instead of a Christmas tree. IMO that's very sad.

  • Reply to

    Trading Insmed

    by bohemianclubman Dec 18, 2015 9:45 AM
    bohemianclubman bohemianclubman Dec 22, 2015 10:24 AM Flag

    lol, "the best biotech market trading conditions in 23 years" and you are trading a low beta biotech!! Your true knowledge of trading is becoming as apparent as your true knowledge of shorting Mr. Uptick... lol, what a putz

  • bohemianclubman by bohemianclubman Dec 18, 2015 9:45 AM Flag

    I'm an investor in INSM and don't trade it at all, but the fact is that experienced traders wouldn't even trade INSM. Beta is a metric of a stocks volatility and real traders trade HIGH beta stocks that move with large percentage swings. With 1 being the average of the market, a stock that trades with a beta of 2 can be expected to move twice as fast as the market. Insmeds beta is between .25 and .30, among the lowest in the biotech sector. Experienced trader and Insmed is an oxymoron, and anyone that uses the two terms together is showing his or her stupidity.

  • Reply to

    PJ event

    by biowatchdog Dec 14, 2015 6:35 PM
    bohemianclubman bohemianclubman Dec 15, 2015 9:59 AM Flag

    Rhoden downgraded Insmed, but remained positive on arikayce for NTM,, just thought that with the time table being pushed back there were some biotechs with more near term catalysts. The downgrade came on November 9, and of the three he suggested 2 are up and one is down. BTW, Insmed is up about 10% since his downgrade.

  • Reply to

    Stu Har

    by insmhistorian Dec 11, 2015 2:11 PM
    bohemianclubman bohemianclubman Dec 14, 2015 10:07 AM Flag

    Lindsey, you are correct. Letting these trolls know that they have elicited our attention is like inviting them to Thanksgiving dinner. Of course he will then smack his lips, belch loudly, stain your tablecloth, and then he will snore loudly while sprawled on the couch during the big game!

  • Reply to

    Experienced Traders

    by bohemianclubman Dec 11, 2015 10:26 AM
    bohemianclubman bohemianclubman Dec 11, 2015 12:56 PM Flag

    lol, well put rocks.... leaving off the "oxy" works just fine for me

  • bohemianclubman by bohemianclubman Dec 11, 2015 10:26 AM Flag

    I'm an investor in INSM and don't trade it at all, but the fact is that experienced traders wouldn't even trade INSM. Beta is a metric of a stocks volatility and real traders trade HIGH beta stocks that move with large percentage swings. With 1 being the average of the market, a stock that trades with a beta of 2 can be expected to move twice as fast as the market. Insmeds beta is between .25 and .30, among the lowest in the biotech sector. Experienced trader and Insmed is an oxymoron, and anyone that uses the two terms together is showing his or her stupidity.

  • Reply to

    Seeds of doubt?

    by biowatchdog Dec 7, 2015 7:39 PM
    bohemianclubman bohemianclubman Dec 11, 2015 9:40 AM Flag

    Slide 38 is also very impressive. The six minute walk test is a secondary endpoint of the 212 Convert Study.

  • Reply to

    What Rave Needs

    by frenchcanadien Dec 7, 2015 7:21 PM
    bohemianclubman bohemianclubman Dec 8, 2015 10:14 AM Flag

    Hi French, with a market cap a mere 60 Million, it has to be difficult to gain much analyst coverage. I would still like to see the company sell off Pizza Inn and IPO Pie Five, except suddenly the price is a bit low to contemplate that. With Chipotle finding it's shares taking a deep swoon it has spread weakness throughout the fast casual space, but nobody here or anywhere could convince me that a 60 million market cap for a company that is rapidly opening restaurants as well as building franchisee relationships, makes any sense whatsoever. Earlier today RAVE had a 20 cent range on 611 shares traded,, crazy....

  • Reply to

    The Financial Times is reporting

    by bohemianclubman Dec 7, 2015 10:37 AM
    bohemianclubman bohemianclubman Dec 7, 2015 10:53 AM Flag

    Just wanted to add that Gilead purchased Pharmasset in 2011, and harvoni to treat Hep C was not approved until 2 years and 11 months later. Gilead payed 11 Billion to purchase a company that would not have an approved drug for nearly three years.

  • bohemianclubman by bohemianclubman Dec 7, 2015 10:37 AM Flag

    That Gilead is about to hit the acquisition trail in a big way. The article says that the company is looking for companies that had phase II results that are likely to lead to approvals.

  • Reply to

    Ask yourself a question......

    by insmhistorian Dec 3, 2015 10:17 PM
    bohemianclubman bohemianclubman Dec 4, 2015 3:34 PM Flag

    Thanks H, I'm sure that most are also not aware that Eleison has in turn sub licensed inhaled cisplatin to a Hong Kong pharmaceutical company for the Chinese market. The two are combining for a large phase II trial.....

  • Reply to

    Ask yourself a question......

    by insmhistorian Dec 3, 2015 10:17 PM
    bohemianclubman bohemianclubman Dec 4, 2015 10:56 AM Flag

    H, do you really believe that it is some posters..... or one poster? PAH trial should begin this month so then you will be receiving the potential of arikayce and trepostinil, as well as potential licensing fees from small cell lung cancer if Eleison is successful.

  • bohemianclubman by bohemianclubman Dec 3, 2015 1:09 PM Flag

    Taken word for word from the comments of an infamous poster here. Who really says that? Everyone is occasionally wrong. However, I still believe that I have yet to be wrong advising posters that actually want to discuss Insmed to completely, totally, unconditionally, utterly, and wholeheartedly ignore this poster.

    When your world revolves around the great and wonderful you, anything that challenges that view will be automatically greeted with an outbreak of disdain and anger....even rage. While such obsessive motive will never be clear to me, it does seem clear such obsessive behavior doesn't deserve any response. JMHO

  • Reply to

    Oh, dear...

    by biowatchdog Dec 2, 2015 11:56 AM
    bohemianclubman bohemianclubman Dec 2, 2015 2:08 PM Flag

    lol H, I'm not confident that Astra Zeneca would not recognize that one of their employees spent all day every day for years and years and years posting on a stock message board.

  • Reply to

    My #23 Pie Five visit...Lots of news

    by den56kk Dec 1, 2015 10:15 AM
    bohemianclubman bohemianclubman Dec 2, 2015 10:50 AM Flag

    Thanks, much appreciated.

  • Reply to

    Happy Thanksgiving, All........

    by insmhistorian Nov 25, 2015 12:15 PM
    bohemianclubman bohemianclubman Nov 25, 2015 12:54 PM Flag

    Happy Thanksgiving H. As difficult as it is I'm willing to go along with you and say Happy Thanksgiving all.

    Bo

  • bohemianclubman bohemianclubman Nov 25, 2015 10:57 AM Flag

    Thanks, interesting how this person that already has three Pie Fives open and has committed to ten thinks that their oven is the best, while some posters on this message board claim differently.... Who to believe? lol

  • Reply to

    New Position

    by checksurshorts Nov 24, 2015 2:33 PM
    bohemianclubman bohemianclubman Nov 25, 2015 9:52 AM Flag

    Hi H, I think he may have meant merger or acquisition since starting in February Lewis has a share buying plan set up which allows him to systematically purchase shares, each quarter, regardless of any material information he may be aware of. When I saw the filing two things immediately occurred to me: One - the company is not currently engaged in any merger or acquisition talks, and Two, the company may be engaged in some strategic talks soon after the calendar turns.

  • Reply to

    Annual Meeting Part 3

    by extra_e_mail Nov 22, 2015 10:05 PM
    bohemianclubman bohemianclubman Nov 23, 2015 3:27 PM Flag

    Thank You. I believe the shorts are, and have been messing with this one. That is the reason that the day they got a BUY rating from Wunderlich Securities the shares ran as much as 4 points. The mother of all short squeezes continues today with KBIO. On Friday the shares closed with a market cap similar to RAVE, and today that market cap has doubled..... again. I can't imagine what a filing declaring a large position in RAVE might do to these shares.

INSM
12.81+0.06(+0.47%)Feb 10 4:00 PMEST